Courtney Gilliland
Family · Opelika, ALNPI 1851779433
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 151 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 33 manufacturers, the largest accounting for just 19.0% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2021 at $807 and has fallen 78.7% since, to $171 in 2025.
Across 151 payments — averaging $16.00 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Lilly USA, LLC$458
- Boehringer Ingelheim$257
- Abbott$194
- GSK$173
- Xeris Pharmaceuticals, Inc.$164
- Novo Nordisk$124
- plus $1K from 27 others
What the payments were for
- Food & beverage$2,415100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Lilly USA, LLC | 33 | $458 |
| Boehringer Ingelheim | 19 | $257 |
| Abbott | 10 | $194 |
| GSK | 10 | $173 |
| Xeris Pharmaceuticals, Inc. | 8 | $164 |
| Novo Nordisk | 7 | $124 |
| AbbVie | 7 | $112 |
| Bayer | 6 | $111 |
| Pfizer | 7 | $101 |
| Astellas Pharma US Inc | 4 | $58 |
| Novartis | 4 | $58 |
| Merck | 4 | $56 |
| AstraZeneca | 3 | $52 |
| Intuitive Surgical | 2 | $47 |
| Sanofi-aventis U.S. LLC | 2 | $37 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 2 | $36 |
| Johnson & Johnson | 2 | $34 |
| Idorsia Pharmaceuticals US Inc | 2 | $33 |
| Kowa Pharmaceuticals America, Inc. | 2 | $30 |
| Exact Sciences | 2 | $29 |
| Eyevance Pharmaceuticals LLC | 2 | $29 |
| Hikma Pharmaceuticals USA | 2 | $29 |
| Dexcom, Inc. | 1 | $26 |
| Otsuka America Pharmaceutical, Inc. | 1 | $25 |
| Genentech USA, Inc. | 1 | $20 |
| Lundbeck LLC | 1 | $19 |
| Amgen | 1 | $19 |
| GE HealthCare | 1 | $17 |
| Esperion Therapeutics, Inc. | 1 | $17 |
| Boston Scientific | 1 | $16 |
| Philips North America LLC | 1 | $15 |
| Teva Pharmaceuticals USA, Inc. | 1 | $15 |
| Phathom Pharmaceuticals, Inc. | 1 | $7 |
How this compares
$2,415 in reported general payments places this provider in the 80th percentile of 3,415 family providers in Alabama.
Other family in Opelika
- Elizabeth KelleyOpelika$12K
- Leigh Ann ChildressHuntsville$240K
- Molly ReevesAuburn$158K
- Christina CanteyHuntsville$118K
- Leigh LunaMontgomery$69K
- Christopher LovellMobile$64K
- Justin SimpsonTuscaloosa$43K
- Kellyn McMahonBirmingham$39K
- Ashley StinesTuscaloosa$29K
- Brandy YoungMontgomery$27K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.